CC BY-NC-ND 4.0 · Journal of Social Health and Diabetes 2019; 7(02): 54-57
DOI: 10.1055/s-0039-3401980
Review Article

Diabetes and Addictive Disorders

Yatan Pal Singh Balhara
1  National Drug Dependence Treatment Center and Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi
,
Sarita Bajaj
2  Department of Medicine, Regional Institute of Medical Sciences, Imphal, India
,
Mangesh Tiwaskar
3  Shilpa Medical Research Center, Mumbai, Maharashtra, India
,
Ameya Joshi
4  Endocrine and Diabetes Clinic Mumbai, Bhaktivedanta Hospital And Research Institute, Thane, Maharashtra, India
,
Vaishali Deshmukh
5  Sassoon General Hospital and BMC, Pune, Maharashtra, India
› Author Affiliations
  

Abstract

Prevalence of addictive disorders among persons with diabetes mellitus (DM) (type 1 and type 2) ranges from 9.6 to 29%. Excessive and problematic use of psychoactive substances in persons with diabetes results in poor glycemic control with frequent hyperglycemic crisis. Tobacco, alcohol, cannabis, benzodiazepines, inhalants, and stimulants are common psychoactive substances used among persons with diabetes in India. The daily use of alcohol by men and women with DM should not exceed 15 and 30 g of ethanol, respectively. Use of other psychoactive substances is not recommended for persons with DM. Various screening tools exist for assessing substance abuse like WHO-ASSIST, Alcohol Use Disorders Identification Test (AUDIT), Fagerström Test for Nicotine Dependence (FTND), and Opioid Risk Tool. Integrated management of co-occurring addictive disorder and DM is recommended. Psychosocial treatments for substances include brief interventions (BIs), motivational interviewing, contingency management, relapse prevention, and cognitive behavior therapy



Publication History

Publication Date:
30 March 2020 (online)

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India